Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2014 | 4.37 Million USD | 50.83% |
| 2013 | 2.9 Million USD | 16.47% |
| 2012 | 2.49 Million USD | -34.62% |
| 2011 | 3.81 Million USD | 23.87% |
| 2010 | 3.07 Million USD | -22.96% |
| 2009 | 3.99 Million USD | -1.71% |
| 2008 | 4.06 Million USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 1.5 Million USD | 248.15% |
| 2005 | 432 Thousand USD | 142.7% |
| 2004 | 178 Thousand USD | -58.67% |
| 2003 | 430.63 Thousand USD | -17.34% |
| 2002 | 520.95 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2015 Q3 | 615.15 Thousand USD | 7.29% |
| 2015 Q1 | 787.03 Thousand USD | -6.83% |
| 2015 Q2 | 573.36 Thousand USD | -27.15% |
| 2014 Q1 | 1.09 Million USD | 106.83% |
| 2014 FY | 4.37 Million USD | 50.83% |
| 2014 Q4 | 844.74 Thousand USD | 71.47% |
| 2014 Q3 | 492.65 Thousand USD | -74.73% |
| 2014 Q2 | 1.94 Million USD | 78.71% |
| 2013 FY | 2.9 Million USD | 16.47% |
| 2013 Q4 | 527.34 Thousand USD | -36.4% |
| 2013 Q1 | 942.91 Thousand USD | 47.12% |
| 2013 Q3 | 829.2 Thousand USD | 37.59% |
| 2013 Q2 | 602.67 Thousand USD | -36.08% |
| 2012 Q4 | 640.89 Thousand USD | 17.12% |
| 2012 Q1 | 568.27 Thousand USD | -54.53% |
| 2012 FY | 2.49 Million USD | -34.62% |
| 2012 Q3 | 547.23 Thousand USD | -25.59% |
| 2012 Q2 | 735.42 Thousand USD | 29.41% |
| 2011 Q4 | 1.24 Million USD | 60.13% |
| 2011 FY | 3.81 Million USD | 23.87% |
| 2011 Q2 | 804.12 Thousand USD | -17.72% |
| 2011 Q3 | 780.44 Thousand USD | -2.94% |
| 2011 Q1 | 977.26 Thousand USD | 4.94% |
| 2010 Q1 | 664.85 Thousand USD | -5.03% |
| 2010 FY | 3.07 Million USD | -22.96% |
| 2010 Q4 | 931.22 Thousand USD | 35.2% |
| 2010 Q3 | 688.77 Thousand USD | -13.05% |
| 2010 Q2 | 792.11 Thousand USD | 19.14% |
| 2009 FY | 3.99 Million USD | -1.71% |
| 2009 Q2 | 1.18 Million USD | 18.63% |
| 2009 Q4 | 700.05 Thousand USD | -36.81% |
| 2009 Q3 | 1.1 Million USD | -6.59% |
| 2009 Q1 | 999.79 Thousand USD | -25.9% |
| 2008 Q3 | 782.83 Thousand USD | -27.42% |
| 2008 FY | 4.06 Million USD | 0.0% |
| 2008 Q4 | 1.34 Million USD | 72.37% |
| 2008 Q1 | 852.37 Thousand USD | 0.0% |
| 2008 Q2 | 1.07 Million USD | 26.54% |
| 2007 Q1 | 914.07 Thousand USD | 0.52% |
| 2007 FY | - USD | -100.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 25.89 Thousand USD | -74.76% |
| 2007 Q2 | 102.6 Thousand USD | -88.78% |
| 2006 Q2 | 25.71 Thousand USD | 2484.42% |
| 2006 Q3 | 567.9 Thousand USD | 2108.45% |
| 2006 FY | 1.5 Million USD | 248.15% |
| 2006 Q4 | 909.38 Thousand USD | 60.13% |
| 2006 Q1 | 995.00 USD | 1375.64% |
| 2005 Q1 | 52.58 Thousand USD | 116.78% |
| 2005 Q4 | -78.00 USD | -100.02% |
| 2005 Q3 | 334.82 Thousand USD | 649.66% |
| 2005 FY | 432 Thousand USD | 142.7% |
| 2005 Q2 | 44.66 Thousand USD | -15.07% |
| 2004 Q1 | 67.01 Thousand USD | -58.85% |
| 2004 Q4 | 24.25 Thousand USD | -42.93% |
| 2004 FY | 178 Thousand USD | -58.67% |
| 2004 Q3 | 42.5 Thousand USD | -3.87% |
| 2004 Q2 | 44.22 Thousand USD | -34.01% |
| 2003 Q1 | 106.22 Thousand USD | 2035.53% |
| 2003 Q4 | 162.83 Thousand USD | 107.15% |
| 2003 Q3 | 78.6 Thousand USD | -5.27% |
| 2003 FY | 430.63 Thousand USD | -17.34% |
| 2003 Q2 | 82.97 Thousand USD | -21.89% |
| 2002 Q4 | -5488.00 USD | -102.89% |
| 2002 Q1 | 157.86 Thousand USD | 0.0% |
| 2002 Q3 | 189.79 Thousand USD | 0.0% |
| 2002 FY | 520.95 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -379.441% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 83.072% |
| Bioqual, Inc. | 58.59 Million USD | 92.529% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 71.383% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.941% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 31.242% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -316.255% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 89.115% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -878.17% |
| InVitro International | 792.62 Thousand USD | -452.251% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 60.675% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 39.408% |
| NovelStem International Corp. | 12 Thousand USD | -36377.5% |
| Optigenex Inc. | 465.97 Thousand USD | -839.395% |
| PharmChem, Inc. | 6.01 Million USD | 27.195% |
| Proteome Sciences plc | 6.4 Million USD | 31.612% |
| Response Genetics, Inc | 18.04 Million USD | 75.736% |
| Rennova Health, Inc. | 13.03 Million USD | 66.422% |
| RushNet, Inc. | 1.78 Million USD | -144.832% |
| ScreenPro Security Inc. | 1.91 Million USD | -128.687% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -15.342% |
| Todos Medical Ltd. | 7.69 Million USD | 43.115% |